BDTX - CIK 0001701541
Black Diamond Therapeutics, Inc. has filed 470 documents with the SEC between 2017 and 2026. The most frequent type is insider trade (237 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| DRS | - | 2019-08-23 | - |